Which statement best describes how to manage impulse-control disorder in a patient on a dopamine agonist?

Study for the Foundation Year Pharmacy – Clinical Practice Test. Prepare with detailed questions, step-by-step explanations, and test format insights. Enhance your readiness and confidence!

Multiple Choice

Which statement best describes how to manage impulse-control disorder in a patient on a dopamine agonist?

Explanation:
When impulse-control problems appear in a patient taking a dopamine agonist, the underlying issue is excessive dopaminergic stimulation of pathways involved in reward and impulse control. Dopamine agonists, especially those with high D3 receptor activity, can amplify these circuits and lead to compulsive behaviors like gambling, binge eating, or hypersexuality. The most effective way to address this is to reduce the dose of the dopamine agonist gradually. Lowering the dose decreases the abnormal stimulation that’s driving the impulses while helping to preserve motor control as much as possible. A slow taper also reduces the risk of withdrawal effects and a rebound worsening of Parkinsonian symptoms, making it safer and more tolerable for the patient. Abruptly stopping all Parkinson’s medications or increasing the dopamine agonist would likely worsen the impulse-control issues or produce other serious motor or withdrawal problems. Simply observing without changing anything wouldn’t relieve the problematic behaviors, and attempting to fix motor symptoms without addressing the dopaminergic overstimulation would miss the root cause of the impulse-control disorder.

When impulse-control problems appear in a patient taking a dopamine agonist, the underlying issue is excessive dopaminergic stimulation of pathways involved in reward and impulse control. Dopamine agonists, especially those with high D3 receptor activity, can amplify these circuits and lead to compulsive behaviors like gambling, binge eating, or hypersexuality.

The most effective way to address this is to reduce the dose of the dopamine agonist gradually. Lowering the dose decreases the abnormal stimulation that’s driving the impulses while helping to preserve motor control as much as possible. A slow taper also reduces the risk of withdrawal effects and a rebound worsening of Parkinsonian symptoms, making it safer and more tolerable for the patient.

Abruptly stopping all Parkinson’s medications or increasing the dopamine agonist would likely worsen the impulse-control issues or produce other serious motor or withdrawal problems. Simply observing without changing anything wouldn’t relieve the problematic behaviors, and attempting to fix motor symptoms without addressing the dopaminergic overstimulation would miss the root cause of the impulse-control disorder.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy